Abstract

KCNQ2 mutations can cause benign familial neonatal convulsions (BFNCs), epileptic encephalopathy (EE), and mild-to-profound neurodevelopmental disabilities. Mutations in the KCNQ2 selectivity filter (SF) are critical to neurodevelopmental outcomes. Three patients with neonatal EE carry de novo heterozygous KCNQ2 p.Thr287Ile, p.Gly281Glu and p.Pro285Thr, and all are followed-up in our clinics. Whole-cell patch-clamp analysis with transfected mutations was performed. The Kv7.2 in three mutations demonstrated significant current changes in the homomeric-transfected cells. The conduction curves for V1/2, the K slope, and currents in 3 mutations were lower than those for the wild type (WT). The p.Gly281Glu had a worse conductance than the p.Thr287Ile and p.Pro285Thr, the patient compatible with p.Gly281Glu had a worse clinical outcome than patients with p.Thr287Ile and p.Pro285Thr. The p.Gly281Glu had more amino acid weight changes than the p.Gly281Glu and p.Pro285Thr. Among 5 BFNCs and 23 EE from mutations in the SF, the greater weight of the mutated protein compared with that of the WT was presumed to cause an obstacle to pore size, which is one of the most important factors in the phenotype and outcome. For the 35 mutations in the SF domain, using changes in amino acid weight between the WT and the KCNQ2 mutations to predict EE resulted in 80.0% sensitivity and 80% specificity, a positive prediction rate of 96.0%, and a negative prediction rate of 40.0% (p = 0.006, χ2 (1, n = 35) = 7.56; odds ratio 16.0, 95% confidence interval, 1.50 to 170.63). The findings suggest that p.Thr287Ile, p.Gly281Glu and p.Pro285Thr are pathogenic to KCNQ2 EE. In mutations in SF, a mutated protein heavier than the WT is a factor in the Kv7.2 current and outcome.

Highlights

  • We demonstrated that patients with KCNQ2 EE exhibited dyskinetic movement disorders and autistic spectrum disorder (ASD) after infantile age and determined that three KCNQ2 variants in the selectivity filter (SF)

  • Patient 1 carried de novo p.Thr287Ile and presented with neonatal seizures since day 3 of life

  • Cells 2022, 11, x FOR PEER REVIEW wild type (WT) and the KCNQ2 mutations to predict EE resulted in 80.0% sensitivity, 80% specificity, 13 of 25 a positive prediction rate of 96.0%, and a negative prediction rate of 40.0% (p = 0.006, χ2 (1, n = 35) = 7.56; odds ratio 16.0, 95% confidence interval, 1.50 to 170.63) (Table 3)

Read more

Summary

Introduction

KCNQ2 (OMIM 602235)-associated seizures typically occur in the first week from birth and can contribute to benign familial neonatal convulsions (BFNCs), benign familial infantile seizures [1–5], and neonatal-onset epileptic encephalopathy (EE) [6–8]. BFNCs are generally predicted to follow a benign course and are expected to have unremarkable outcomes. Patients with KCNQ2 EE present with severe seizures that often remit as patients become older; such patients experience poor neurodevelopmental outcomes in terms of cognition, motor skills, and language, and they may exhibit autistic spectrum disorder (ASD). This condition is called developmental EE [9,10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call